vs
EMPIRE PETROLEUM CORP（EP）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是EMPIRE PETROLEUM CORP的1.3倍（$9.1M vs $7.1M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -835.1%，领先774.8%），EMPIRE PETROLEUM CORP同比增速更快（-30.0% vs -49.9%），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -13.3%）
伊拉克石油公司，前身为土耳其石油公司，是一家石油企业，1925年至1961年间几乎垄断了伊拉克境内所有石油勘探与开采业务，由当时全球多家顶尖石油企业共同持股，公司总部设立于英国伦敦。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
EP vs PLX — 直观对比
营收规模更大
PLX
是对方的1.3倍
$7.1M
营收增速更快
EP
高出19.9%
-49.9%
净利率更高
PLX
高出774.8%
-835.1%
两年增速更快
PLX
近两年复合增速
-13.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.1M | $9.1M |
| 净利润 | $-59.0M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | -834.5% | -51.1% |
| 净利率 | -835.1% | -60.3% |
| 营收同比 | -30.0% | -49.9% |
| 净利润同比 | -1306.0% | -184.8% |
| 每股收益（稀释后） | $-1.74 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPPLX
| Q4 25 | $7.1M | $9.1M | ||
| Q3 25 | $9.4M | $17.9M | ||
| Q2 25 | $8.8M | $15.7M | ||
| Q1 25 | $9.0M | $10.1M | ||
| Q4 24 | $10.1M | $18.2M | ||
| Q3 24 | $11.4M | $18.0M | ||
| Q2 24 | $12.8M | $13.5M | ||
| Q1 24 | $9.4M | — |
净利润EPPLX
| Q4 25 | $-59.0M | $-5.5M | ||
| Q3 25 | $-3.8M | $2.4M | ||
| Q2 25 | $-5.1M | $164.0K | ||
| Q1 25 | $-4.2M | $-3.6M | ||
| Q4 24 | $-4.2M | $6.5M | ||
| Q3 24 | $-3.6M | $3.2M | ||
| Q2 24 | $-4.4M | $-2.2M | ||
| Q1 24 | $-4.0M | — |
毛利率EPPLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
营业利润率EPPLX
| Q4 25 | -834.5% | -51.1% | ||
| Q3 25 | -37.8% | 11.9% | ||
| Q2 25 | -56.0% | 7.5% | ||
| Q1 25 | -43.9% | -41.0% | ||
| Q4 24 | -38.9% | 39.6% | ||
| Q3 24 | -30.0% | 22.2% | ||
| Q2 24 | -15.0% | -18.0% | ||
| Q1 24 | -46.8% | — |
净利率EPPLX
| Q4 25 | -835.1% | -60.3% | ||
| Q3 25 | -40.9% | 13.2% | ||
| Q2 25 | -57.8% | 1.0% | ||
| Q1 25 | -46.9% | -35.8% | ||
| Q4 24 | -41.6% | 35.6% | ||
| Q3 24 | -32.0% | 18.0% | ||
| Q2 24 | -34.3% | -16.4% | ||
| Q1 24 | -42.3% | — |
每股收益（稀释后）EPPLX
| Q4 25 | $-1.74 | $-0.06 | ||
| Q3 25 | $-0.11 | $0.03 | ||
| Q2 25 | $-0.15 | $0.00 | ||
| Q1 25 | $-0.12 | $-0.05 | ||
| Q4 24 | $-0.12 | $0.10 | ||
| Q3 24 | $-0.12 | $0.03 | ||
| Q2 24 | $-0.15 | $-0.03 | ||
| Q1 24 | $-0.15 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-4.6M | $48.2M |
| 总资产 | $65.9M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EPPLX
| Q4 25 | $1.2M | $14.7M | ||
| Q3 25 | $4.6M | $13.6M | ||
| Q2 25 | $2.3M | $17.9M | ||
| Q1 25 | $1.1M | $19.5M | ||
| Q4 24 | $2.3M | $19.8M | ||
| Q3 24 | $3.1M | $27.4M | ||
| Q2 24 | $9.3M | $23.4M | ||
| Q1 24 | $3.5M | — |
总债务EPPLX
| Q4 25 | — | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $14.6M | — | ||
| Q1 25 | $11.6M | — | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.5M | — |
股东权益EPPLX
| Q4 25 | $-4.6M | $48.2M | ||
| Q3 25 | $53.7M | $52.9M | ||
| Q2 25 | $54.5M | $49.9M | ||
| Q1 25 | $59.1M | $45.2M | ||
| Q4 24 | $62.8M | $43.2M | ||
| Q3 24 | $56.5M | $32.4M | ||
| Q2 24 | $58.7M | $28.6M | ||
| Q1 24 | $31.7M | — |
总资产EPPLX
| Q4 25 | $65.9M | $82.3M | ||
| Q3 25 | $123.0M | $82.3M | ||
| Q2 25 | $124.7M | $78.5M | ||
| Q1 25 | $123.7M | $73.9M | ||
| Q4 24 | $123.9M | $73.4M | ||
| Q3 24 | $121.2M | $61.6M | ||
| Q2 24 | $119.9M | $91.5M | ||
| Q1 24 | $100.1M | — |
负债/权益比EPPLX
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流EPPLX
| Q4 25 | $-2.8M | $2.0M | ||
| Q3 25 | $330.0K | $-3.7M | ||
| Q2 25 | $-3.1M | $-5.2M | ||
| Q1 25 | $1.6M | $-5.1M | ||
| Q4 24 | $-8.8M | $4.0M | ||
| Q3 24 | $12.8M | $4.1M | ||
| Q2 24 | $-1.8M | $-3.6M | ||
| Q1 24 | $3.9M | — |
自由现金流EPPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q1 24 | — | — |
自由现金流率EPPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | — | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q1 24 | — | — |
资本支出强度EPPLX
| Q4 25 | — | 4.4% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | — |
现金转化率EPPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EP
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
